Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.
about
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosusCurrent treatment of antiphospholipid syndrome: lights and shadows.Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review.Cerebral embolism from Libman-Sacks endocarditis.Acute myocardial infarction in young adults with antiphospholipid syndrome: report of two cases and literature review.Nonorgan specific autoantibodies and heart damage.Cardiac involvement in the antiphospholipid syndrome.Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.Current management of antiphospholipid syndrome-related thrombosis.Valvular heart disease in antiphospholipid syndrome.Pulmonary hypertension in antiphospholipid syndrome.Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?Recurrent stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness.Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?Patent foramen ovale and atrial septal aneurysm can cause ischemic stroke in patients with antiphospholipid syndrome.Conventional and targeted medical therapies.Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.
P2860
Q28072610-41207E08-9675-496E-8B88-FD3285AC8755Q33423959-AA4D5143-C0D3-427D-9E6B-55FB56145601Q34590968-1DB6D6EC-E277-4205-AA2D-7B020EC3FD5BQ35094631-755F32EF-DB0D-40A9-AACF-F40500C68294Q35444451-F7897BAB-813B-4309-8D08-E539EB540FA6Q36283415-FA6B343F-A12E-4811-8C14-A87AED1518FFQ36283448-2A686E99-1881-4DD8-B591-D4DED4FC6164Q36596375-C3BDE76D-0373-4145-BE08-E596FA552700Q37642830-A4B2ED9F-1BFE-4730-A18C-1903C186DBE1Q38086166-C6BEC359-9AD9-4918-A72E-EC10C4FC779FQ38325716-A2169362-C85A-4BAC-A33F-5CD04A71C82AQ41700174-F0B0822A-421E-459D-B909-D505B31A036DQ41830826-DC7D9512-ACF0-4597-80FC-E5AFFF9A7206Q43901099-B8E40D2E-0E00-4721-B750-55F0E80DCA24Q44811981-03E2DAEA-F0BA-4899-A2D5-26E7C3402034Q45344078-CDAD22B7-9607-4C44-B9D5-71B260B6CD12Q46023621-749DE857-1208-441C-8CD0-D65EB40B8037Q48035289-35671725-179B-424B-8B00-8A8171987EEFQ53159273-A730B00C-F105-4074-A9B9-1C9FC2239255Q55407136-315F8479-4A5C-4329-9C39-A2A8FF1DAA37Q55440072-2625E771-F619-4B72-9613-F9483449E68E
P2860
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cardiac disease in the antipho ...... t. Committee consensus report.
@ast
Cardiac disease in the antipho ...... t. Committee consensus report.
@en
type
label
Cardiac disease in the antipho ...... t. Committee consensus report.
@ast
Cardiac disease in the antipho ...... t. Committee consensus report.
@en
prefLabel
Cardiac disease in the antipho ...... t. Committee consensus report.
@ast
Cardiac disease in the antipho ...... t. Committee consensus report.
@en
P2093
P2860
P50
P1433
P1476
Cardiac disease in the antipho ...... t. Committee consensus report.
@en
P2093
P2860
P304
P356
10.1191/0961203303LU391OA
P577
2003-01-01T00:00:00Z